Goldman Sachs Group Inc Amphastar Pharmaceuticals, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 427,835 shares of AMPH stock, worth $12.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
427,835
Previous 449,389
4.8%
Holding current value
$12.2 Million
Previous $21.8 Million
27.16%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$169 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$77.2 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$52.3 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$45.4 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$39.1 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.39B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...